Jump to content

Dead-end pages

The following pages do not link to other pages in CAMIH.

Showing below up to 50 results in range #51 to #100.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Property:Gender
  2. Property:Gender specifications
  3. Property:Inclusion criteria
  4. Property:Intervention
  5. Property:Is randomized
  6. Property:Journal
  7. Property:LoE
  8. Property:Measurement of compliance
  9. Property:Meta analysis
  10. Property:Mono- or multicentric
  11. Property:N randomized
  12. Property:Number of arms
  13. Property:Number of databases
  14. Property:Number of examined persons
  15. Property:Number of included studies
  16. Property:Number of participants (arm)
  17. Property:Number of studies (arm)
  18. Property:One-time application
  19. Property:Order number
  20. Property:Other explanations for an effect besides the investigated intervention
  21. Property:Other reasons
  22. Property:Other sources of bias
  23. Property:Outcome name
  24. Property:Outcome specification
  25. Property:Outcome timeline
  26. Property:Outcome topic
  27. Property:Outcome type
  28. Property:Overall Drop-out
  29. Property:Overall RoB judgment
  30. Property:Overall confidence in the results of the review
  31. Property:Perspective
  32. Property:Possibility of attention effects
  33. Property:Possibility of placebo effects
  34. Property:Power analysis performed
  35. Property:Previous cancer therapies
  36. Property:Publication year
  37. Property:Reasons given for samples being too small according to power analysis
  38. Property:Reference
  39. Property:Results after intervention
  40. Property:Results during intervention
  41. Property:Sample size corresponds to power analysis
  42. Property:Samples sufficiently large
  43. Property:Search period end
  44. Property:Search period start
  45. Property:Setting
  46. Property:Side Effects / Interactions
  47. Property:Side effects taken into account in the interpretation of the results
  48. Property:Specifications concerning AMSTAR 2 tool
  49. Property:Specifications on analyses
  50. Property:Specifications on cancer therapies

View ( | ) (20 | 50 | 100 | 250 | 500)